边缘区B细胞对A型血友病小鼠凝血因子VIII抑制物形成至关重要
研究在FVIII缺陷小鼠中探索FVIII抑制物形成的早期调控机制,发现注射后FVIII定位于脾边缘窦并与边缘区(MZ)B细胞显著共定位,特异性清除MZ B细胞可完全预防FVIII输注后的抑制物产生,且MZ B细胞重建后再次攻击FVIII仅引发初次抗体反应,表明未诱导免疫耐受;在病毒样佐剂聚肌胞苷酸增强抗FVIII抗体形成的炎症条件下,MZ B细胞清除仍显示类似预防效果。数据强烈提示MZ B细胞在启动FVIII抑制物形成中起关键作用,并提示预防A型血友病患者抗FVIII同种抗体形成的潜在策略。
要点
- FVIII注射后定位于FVIII缺陷小鼠脾边缘窦,与边缘区B细胞显著共定位。
- 特异性清除边缘区B细胞可完全预防FVIII输注后抑制物形成。
- 边缘区B细胞重建后再次攻击FVIII仅引发初次抗体反应,未诱导免疫耐受。
核心结论
- 数据强烈提示边缘区B细胞在启动FVIII抑制物形成中起关键作用,并提示预防A型血友病患者抗FVIII同种抗体形成的潜在策略。
研究设计与样本
- 研究在FVIII缺陷小鼠中定义FVIII抑制物形成的早期调控因子,包括FVIII定位、边缘区B细胞清除及重建后再次攻击实验,并在聚肌胞苷酸炎症条件下评估边缘区B细胞清除效果。
主要发现
- FVIII注射后不久定位于FVIII缺陷小鼠脾边缘窦,与边缘区B细胞显著共定位。
- 特异性清除边缘区B细胞完全预防FVIII输注后抑制物形成。
- 边缘区B细胞重建后再次攻击FVIII引发初次抗体反应,表明清除未导致FVIII耐受。
- 聚肌胞苷酸增强抗FVIII抗体形成,但边缘区B细胞清除在该炎症条件下仍显示类似预防抑制物形成的效果。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although factor VIII (FVIII) replacement therapy can be lifesaving for patients with hemophilia A, neutralizing alloantibodies to FVIII, known as inhibitors, develop in a significant number of patients and actively block FVIII activity, making bleeding difficult to control and prevent. Although a variety of downstream immune factors likely regulate inhibitor formation, the identification and subsequent targeting of key initiators in inhibitor development may provide an attractive approach to prevent inhibitor formation before amplification of the FVIII immune response occurs. As the initial steps in FVIII inhibitor development remain incompletely understood, we sought to define early regulators of FVIII inhibitor formation. Our results demonstrate that FVIII localizes in the marginal sinus of the spleen of FVIII-deficient mice shortly after injection, with significant colocalization with marginal zone (MZ) B cells. FVIII not only colocalizes with MZ B cells, but specific removal of MZ B cells also completely prevented inhibitor development following FVIII infusion. Subsequent rechallenge with FVIII following MZ B-cell reconstitution resulted in a primary antibody response, demonstrating that MZ B-cell depletion did not result in FVIII tolerance. Although recipient exposure to the viral-like adjuvant polyinosinic:polycytidylic acid enhanced anti-FVIII antibody formation, MZ B-cell depletion continued to display similar effectiveness in preventing inhibitor formation following FVIII infusion in this inflammatory setting. These data strongly suggest that MZ B cells play a critical role in initiating FVIII inhibitor formation and suggest a potential strategy to prevent anti-FVIII alloantibody formation in patients with hemophilia A.
引用
- Zerra PE, Cox C, Baldwin WH, et al. Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood. 2017. PMID: 28978569. doi:10.1182/blood-2017-05-782912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。